Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Ribavirin 40-mg/mL Suspension

Author(s):  Allen Loyd V Jr

Issue:  Jul/Aug 2007 - Hormone Replacement Therapy
View All Articles in Issue

Page(s):  334

Ribavirin 40-mg/mL Suspension Page 1

Download in electronic PDF format for $65

Abstract:  A formulation for preparing Ribavirin 40-mg/mL Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, ribavirin, antiviral agent, formulation, viral infection, virus, acute respiratory syndrome

Related Categories: FORMULATIONS, INFECTIOUS DISEASE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Ribavirin 40-mg/mL Suspension
Allen Loyd V Jr
Jul/Aug 2007
Pg. 334

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature
Larson Bayli
, Bushman Lane R, Casciano Matthew L, Oldland Alan R, Kiser Jennifer J, Kiser Tyree H
Nov/Dec 2016
Pg. 521-525

Foscarnet Sodium 24-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 336

Topical Cidofovir for Treatment of Resistant Viral Infections
McElhiney Linda F
Sep/Oct 2006
Pg. 324-328

Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome
Mathews Elizabeth
Sep/Oct 2000
Pg. 334

Stability of Extemporaneous Oral Ribavirin Liquid Preparation
Chan John P
, Tong Henry H Y, Chow Alber H L
Nov/Dec 2004
Pg. 486-488

Aztreonam Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 60

Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment
Riepl Mike
Mar/Apr 2023
Pg. 98-107